CORRECTED-BRIEF-ADMA Biologics Q4 Revenue USD 139.2 Million

Reuters02-26
CORRECTED-BRIEF-<a href="https://laohu8.com/S/ADMA">ADMA Biologics</a> Q4 Revenue USD 139.2 Million

Feb 25 (Reuters) - ADMA Biologics Q4 adjusted net income USD 52.6 million.

  • Q4 net income USD 49.4 million
  • Q4 adjusted EBITDA USD 73.6 million
  • outlook FY revenue USD 635 million

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment